FrancophonIA/ELRC3.0 huggingface dataset:
English: One study compared Ristaben with glipizide (a sulphonylurea), when they were used as an add-on to metformin in 1,172 patients.
Slovenian: V eni študiji so pri 1 172 bolnikih primerjali zdravilo Ristaben z glipizidom (sulfonilsečnino), kadar sta bila uporabljena kot dodatek k metforminu.
English: What is Ristaben used for?
Slovenian: Za kaj se zdravilo Ristaben uporablja?
English: • in combination with metformin or a PPAR-gamma agonist (a type of diabetes medicine) such as a thiazolidinedione, in patients who are not satisfactorily controlled on metformin or the PPARgamma agonist used on its own;
Slovenian: • v kombinaciji z metforminom ali agonistom PPAR-gama (vrsto zdravila proti sladkorni bolezni), kot je tiazolidinedion, pri bolnikih, katerih bolezen samo z metforminom ali agonistom PPAR-gama ni zadovoljivo nadzorovana;
English: • in combination with a sulphonylurea (another type of diabetes medicine) in patients who are not satisfactorily controlled with a sulphonylurea used on its own and in whom metformin is not suitable;
Slovenian: • v kombinaciji s sulfonilsečnino (drugo vrsto zdravila proti sladkorni bolezni) pri bolnikih, katerih nadzor na boleznijo s sulfonilsečnino, uporabljeno samostojno, ni zadosten in za katere zdravljenje z metforminom ni primerno;
English: How has Ristaben been studied?
Slovenian: Kako je bilo zdravilo Ristaben raziskano?
English: How is Ristaben used?
Slovenian: Kako se zdravilo Ristaben uporablja?
English: HbA1c levels were reduced by 1.03% after 18 weeks in patients adding Ristaben to metformin and rosiglitazone, compared with a fall of 0.31% in those adding placebo.
Slovenian: Ravni HbA1c so se pri bolnikih, pri katerih so dodajali zdravilo Ristaben metforminu in rosiglitazonu, po 18 tednih zmanjšale za 1,03 %, v primerjavi z zmanjšanjem za 0,31 % pri bolnikih, pri katerih so dodajali placebo.
English: How does Ristaben work?
Slovenian: Kako zdravilo Ristaben deluje?
English: The other study compared Ristaben with metformin, used on their own, in 1,058 patients;
Slovenian: V drugi študiji so pri 1 058 bolnikih primerjali zdravilo Ristaben z metforminom, oba uporabljena kot samostojni zdravili;
English: What is Ristaben?
Slovenian: Kaj je zdravilo Ristaben?
English: When added to pioglitazone, Ristaben reduced HbA1c levels by 0.85% after 24 weeks, compared with a fall of 0.15% in the patients adding placebo.
Slovenian: Dodajanje zdravila Ristaben pioglitazonu je po 24 tednih vplivalo na zmanjšanje ravni HbA1c za 0,85 %, medtem ko se je pri bolnikih ob dodajanju placeba ta raven zmanjšala za
English: HbA1c levels by 0.67% after 24 weeks, compared with a fall of 0.02% in the patients adding placebo.
Slovenian: Dodajanje zdravila Ristaben metforminu je po 24 tednih vplivalo na zmanjšanje ravni HbA1c za 0,67 %, medtem ko se je pri bolnikih ob dodajanju placeba ta raven zmanjšala za 0,02 %.
English: MA (EU) Numbers (Invented) name
Slovenian: Številka (EU) dovoljenja za promet
English: The marketing authorisation is valid for an unlimited period.
Slovenian: Dovoljenje za promet velja za nedoločen čas.
English: Ablavar was studied in four studies involving 693 patients.
Slovenian: Zdravilo Ablavar je bilo raziskano v štirih študijah, v katere je bilo vključenih 693 bolnikov.
English: The name of the medicine was changed to Ablavar on 10 January 2011.
Slovenian: Ime zdravila je bilo 10. januarja 2011 spremenjeno v Ablavar.
English: Previously known as Vasovist.
Slovenian: 1 Prej znano kot Vasovist.
English: The marketing authorisation holder is TMC Pharma Services Ltd.
Slovenian: Imetnik dovoljenja za promet z zdravilom je družba TMC Pharma Services Ltd.
English: The European Commission granted a marketing authorisation valid throughout the European Union for Vasovist on 3 October 2005.
Slovenian: Evropska komisija je dovoljenje za promet z zdravilom Ablavar, veljavno po vsej Evropski uniji, odobrila dne 3. oktobra 2005.
English: As a result of this interaction, the water molecules give a stronger signal, and this helps to obtain a brighter picture.
Slovenian: Zaradi tega medsebojnega delovanja dajejo vodne molekule močnejši signal, kar omogoča jasnejšo sliko.
English: Other information about Ablavar:
Slovenian: Druge informacije o zdravilu Ablavar:
English: Ablavar also improved the accuracy and specificity of the diagnosis.
Slovenian: Zdravilo Ablavar je izboljšalo tudi natančnost in specifičnost diagnoze.
English: Ablavar gadofosveset trisodium
Slovenian: Ablavar trinatrijev gadofosveset
English: For more information about treatment with Ablavar, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Slovenian: Za več informacij o zdravljenju z zdravilom Ablavar preberite navodilo za uporabo (ki je prav tako del EPAR) ali se posvetujte s svojim zdravnikom ali farmacevtom.
English: This document is a summary of the European public assessment report (EPAR) for Ablavar.
Slovenian: Ta dokument je povzetek evropskega javnega poročila o oceni zdravila (EPAR) za zdravilo Ablavar.
English: Imaging can start immediately after the injection, and can continue for up to one hour after Ablavar is injected.
Slovenian: Slikanje se lahko začne takoj po injiciranju in se lahko nadaljuje uro po prejemu zdravila Ablavar.
English: The sensitivity was improved by between 6 and 42%, which means that between 6 and 42% more stenoses were detected when Ablavar was used than when it was not used.
Slovenian: Občutljivost slikanja se je povečala za 6 do 42 %, kar pomeni, da je bilo ob uporabi zdravila Ablavar ugotovljenih 6 do 42 % več stenoz kot brez njegove uporabe.
English: The CHMP decided that Ablavar's benefits are greater than its risks and recommended that it be given marketing authorisation.
Slovenian: CHMP je zaključil, da so koristi zdravila Ablavar večje od z njim povezanih tveganj, in priporočil, da se zanj odobri dovoljenje za promet.
English: What benefit has Ablavar shown during the studies?
Slovenian: Kakšne koristi je zdravilo Ablavar izkazalo med študijami?
English: The measure of effectiveness was based on the improvement in the detection of stenoses (narrowing of the blood vessels) that reduced the width of the vessel by 50% or more.
Slovenian: Merilo učinkovitosti je temeljilo na izboljšanju ugotavljanja stenoz (zoženja krvnih žil), pri katerih je bila širina žil zmanjšana za 50 % ali več.
English: The most common side effects with Ablavar (seen in more than 1 patient in 100) are headache, paraesthesia (unusual sensations like pins and needles), dysgeusia (taste disturbances), a burning sensation, vasodilatation (widening of the blood vessels, including reddening of the skin), nausea (feeling sick), pruritus (itching) and feeling cold. For the full list of all side effects reported with Ablavar, see the package leaflet.
Slovenian: Najpogostejši neželeni učinki zdravila Ablavar (opaženi pri več kot 1 bolniku od 100) so glavobol, parestezija (nenavadni občutki zbadanja), dizgevzija (motnje okušanja), pekoč občutek, vazodilatacija (širjenje krvnih žil, vključno s pordelostjo kože), navzeja (slabost), pruritus (srbenje) in občutek mrazenja.
English: Ablavar should only be used by doctors who have experience in diagnostic imaging.
Slovenian: Zdravilo Ablavar smejo uporabljati le zdravniki, ki imajo izkušnje z diagnostičnim slikanjem.
English: It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Ablavar.
Slovenian: Pojasnjuje, kako je Odbor za zdravila za uporabo v humani medicini (CHMP) ocenil zdravilo Ablavar, na podlagi česar je oblikoval mnenje za odobritev dovoljenja za promet z njim in priporočila glede pogojev njegove uporabe.
English: In Ablavar, the gadolinium is attached to another chemical so that the metal is not released in the body, and prepared so that it attaches to proteins in the blood.
Slovenian: V zdravilu Ablavar je gandolinij vezan na drugo kemično snov, ki preprečuje sprostitev kovine v telo, in pripravljen za vezavo na beljakovine v krvi.
English: MRI is an imaging method that relies on the tiny magnetic fields produced by water molecules in the body.
Slovenian: To je metoda slikanja, ki temelji na majhnih magnetnih poljih, ki jih ustvarijo vodne molekule v telesu.
English: Ablavar is for diagnostic use.
Slovenian: Zdravilo Ablavar je namenjeno diagnostični uporabi.
English: Ablavar is given as an injection into a vein lasting about 30 seconds.
Slovenian: Zdravilo Ablavar se injicira v veno približno 30 sekund.
English: Patients were having scans because of potential problems with the blood vessels that supply blood to the legs, the kidneys or the feet.
Slovenian: Pri bolnikih je bilo slikanje opravljeno zaradi morebitnih težav s krvnimi žilami, ki dovajajo kri v noge, ledvica in stopala.
English: What is the risk associated with Ablavar?
Slovenian: Kakšna tveganja so povezana z zdravilom Ablavar?
English: It is used in patients who are undergoing magnetic resonance angiography (MRA), a procedure where pictures of the flow of the blood in the body are taken using a scan called magnetic resonance imaging (MRI).
Slovenian: Uporablja se pri bolnikih, ki jih preiskujejo z magnetnoresonančno angiografijo (MRA), tj. postopkom, s katerim se slika pretok krvi v telesu z uporabo magnetnoresonančnega slikanja (MRI).
English: Ablavar should not be used in people who may be hypersensitive (allergic) to gadofosveset trisodium or any of the other ingredients.
Slovenian: Zdravila Ablavar ne smejo uporabljati osebe, ki utegnejo biti preobčutljive za (alergične na) trinatrijev gadosveset ali katero koli drugo sestavino zdravila.
English: Doctors should avoid using Ablavar in patients who have severe kidney problems or who have recently had or are about to have a liver transplant.
Slovenian: Zdravniki naj zdravila Ablavar raje ne uporabljajo pri bolnikih, ki imajo hude težave z ledvicami ali pri katerih je bila nedavno ali bo opravljena presaditev jeter.
English: Why has Ablavar been approved?
Slovenian: Zakaj je bilo zdravilo Ablavar odobreno?
English: All of the patients first had a scan using the standard X-ray method (angiography), followed by MRI scans without or with Ablavar used as a contrast enhancer.
Slovenian: Vsi bolniki so bili najprej slikani s standardnim rentgenskim slikanjem (angiografijo), ki mu je sledilo magnetnoresonančno slikanje z zdravilom Ablavar, uporabljenim kot sredstvom za povečanje kontrasta.
English: more than one dose during each MRI scan, and there should be a gap of at least a week between each Ablavar injection.
Slovenian: lahko ti bolniki med vsakim magnetnoresonančnim slikanjem prejmejo samo en odmerek zdravila, med dvema injiciranjema pa mora preteči najmanj en teden.
English: This means that the gadolinium stays in the blood long enough for a good scan to be obtained.
Slovenian: To pomeni, da ostane v krvi dovolj dolgo, kar omogoča kakovostno slikanje.
English: Gadolinium is used as a ‘contrast enhancer' to help obtain better pictures with MRI scanners.
Slovenian: Gadolinij se uporablja kot sredstvo za povečanje kontrasta, kar zagotavlja boljše slike, izdelane z magnetnoresonančnim slikanjem (MRI).
English: Ablavar is a solution for injection that contains the active substance gadofosveset trisodium.
Slovenian: Zdravilo Ablavar je raztopina za injiciranje, ki vsebuje zdravilno učinkovino trinatrijev gadofosveset.
English: The active substance in Ablavar, gadofosveset trisodium, contains gadolinium, a ‘rare-earth' metal element.
Slovenian: Zdravilna učinkovina zdravila Ablavar, trinatrijev gadofosveset, vsebuje redko zemeljsko kovino gadolinij.
English: Ablavar is used to obtain a clearer scan in patients who have suspected or known problems with blood vessels in the abdomen (tummy) or limbs.
Slovenian: Zdravilo Ablavar se uporablja za pridobivanje jasnejše slike pri bolnikih z domnevnimi ali znanimi težavami s krvnimi žilami v trebuhu ali okončinah.
English: Using Ablavar as an enhancer improved the performance of the scans.
Slovenian: Z uporabo zdravila Ablavar kot sredstva za povečanje kontrasta se je izboljšala učinkovitost slikanja.
English: The full EPAR for Ablavar can be found here.
Slovenian: Celotno evropsko javno poročilo o oceni zdravila (EPAR) za zdravilo Ablavar je na voljo tukaj.
English: Once injected, gadolinium interacts with the water molecules.
Slovenian: Gadolinij in vodne molekule po injiciranju delujejo drug na drugega.
English: How has Ablavar been studied?
Slovenian: Kako je bilo zdravilo Ablavar raziskano?
English: What is Ablavar?
Slovenian: Kaj je zdravilo Ablavar?
English: What is Ablavar used for?
Slovenian: Za kaj se zdravilo Ablavar uporablja?
English: How is Ablavar used?
Slovenian: Kako se zdravilo Ablavar uporablja?
English: If Ablavar is essential, these patients should receive no
Slovenian: Če je zdravilo Ablavar vseeno potrebno,
English: The active substance being a principle of biological origin intended to produce passive immunity is not within the scope of Regulation (EC) No 470/2009.
Slovenian: Učinkovina, ki je v osnovi biološkega izvora namenjena vzbujanju pasivne imunosti, ne spada v področje uporabe Uredbe (ES) št. 470/2009.
English: Interaction with other medicinal products and other forms of interaction: No data available.
Slovenian: Medsebojno delovanje z drugimi zdravili in druge oblike interakcij: Ni podatkov.
English: The excipients listed in section 6.1 of the SPC are either allowed substances for which table 1 of the annex to Commission Regulation (EU) No 37/2010 indicates that no MRLs are required or are considered as not falling within the scope of Regulation (EC) No 470/2009 when used as in this veterinary medicinal product.
Slovenian: Pomožne snovi, navedene v poglavju 6.1 SPC, so bodisi dovoljene snovi, za katere tabela 1 priloge Uredbe Komisije (EU) št. 37/2010 določa, da MRL ni potreben, ali pa ne spadajo v področje uporabe Uredbe (ES) št. 470/2009, kadar so uporabljene tako kot v tem zdravilu za uporabo v veterinarski medicini.
English: Detailed information on this veterinary medicinal product is available on the website of the European Medicines Agency (http://www.ema.europa.eu/).
Slovenian: Podrobne informacije o tem zdravilu so na voljo na spletni strani Evropske agencije za zdravila (European Medicines Agency) http://www.ema.europa.eu/.
English: MARKETING AUTHORISATION NUMBER(S) EU/2/18/228/001
Slovenian: ŠTEVILKA(E) DOVOLJENJ(A) ZA PROMET EU/2/18/228/001
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 29/03/2019
Slovenian: DATUM PRIDOBITVE/PODALJŠANJA DOVOLJENJA ZA PROMET Datum pridobitve dovoljenja za promet: 29/03/2019
English: 4.10 Overdose (symptoms, emergency procedures, antidotes), if necessary
Slovenian: 4.10 Preveliko odmerjanje (simptomi, nujni ukrepi, protistrupi) (če je potrebno) Ni podatkov.
English: PROHIBITION OF SALE, SUPPLY AND/OR USE Not applicable
Slovenian: PREPOVED PRODAJE, OSKRBE IN/ALI UPORABE
English: No data available.
Slovenian: Ni podatkov.
English: Colourless and clear suspension.
Slovenian: Brezbarvna in bistra suspenzija.
English: Pharmacotherapeutic group: {not yet assigned} ATCvet code: {not yet assigned}
Slovenian: Farmakoterapevtska skupina: {še ni bila dodeljena} Oznaka ATC vet: {še ni bila dodeljena}
English: Dulbecco's Modified Eagle Medium Low Glucose
Slovenian: Dulbeccovo modificirano Eaglovo gojišče z nizko vsebnostjo glukoze
English: For any further information about this veterinary medicinal product, please contact the local representative of the marketing authorisation holder.
Slovenian: Za vse nadaljnje informacije o tem zdravilu se obrnite na krajevno predstavništvo imetnika dovoljenja za promet z zdravilom.
English: Using appropriate gloves, remove the two vials (one vial of cells (1 ml) and one vial of EAP (1ml)) from the freezer/liquid nitrogen and thaw immediately at 25 °C - 37 °C, e.g. in a water bath, until the contents in each are completely thawed (approximately 5 minutes).
Slovenian: S primernimi rokavicami vzemite dve viali (eno vialo s celicami (1 ml) in eno vialo z EAP (1 ml)) iz zamrzovalnika/tekočega dušika in ju takoj odtalite pri temperaturi 25-37 °C, npr. v vodni kopeli, dokler se vsebina obeh popolnoma ne odtali (približno 5 minut).
English: - very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
Slovenian: - zelo redki (pri manj kot 1 živali od 10 000 zdravljenih živali, vključno s posameznimi primeri).
English: In an experimental model of osteoarthritis in horses these effects were reflected through parameters related to cartilage turnover.
Slovenian: V poskusnem modelu osteoartritisa pri konjih so se ti učinki pokazali v obliki parametrov, povezanih s premeno hrustanca.
English: Efficacy data are not available regarding treatment of other joints.
Slovenian: Podatki o učinkovitosti pri zdravljenju drugih sklepov niso na voljo.
English: The product must be manipulated and injected using sterile techniques and in a clean environment.
Slovenian: Z zdravilom je treba ravnati in ga injicirati sterilno, v čistem okolju.
English: Do not use this veterinary medicinal product after the expiry date which is stated on the labels.
Slovenian: Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, navedenega na ovojnini.
English: The addition of the EAP to the stem cells after thawing and just before injection of the product increases the viability of the stem cells.
Slovenian: Dodatek EAP matičnim celicam po odtalitvi in tik pred injiciranjem zdravila poveča zmožnost preživetja matičnih celic.
English: Then mix both the suspensions in the same syringe to produce one dose of the product (2 ml).
Slovenian: Nato zmešajte obe suspenziji v isti injekcijski brizgi, da nastane en odmerek zdravila (2 ml).
English: Do not administer simultaneously with any other intraarticular veterinary medicinal product.
Slovenian: Ne dajajte hkrati z nobenim drugim intraartikularnim zdravilom za uporabo v veterinarski medicini.
English: Each pack (polycarbonate container) contains a single dose of the product: one vial of stem cell suspension and one vial of EAP suspension.
Slovenian: Eno pakiranje (vsebnik iz polikarbonata) vsebuje en odmerek zdravila: eno vialo s suspenzijo matičnih celic in eno vialo s suspenzijo EAP.
English: After injection of the product the stem cells do not migrate or distribute from the treated joint and synovia to tissues surrounding the synovial space.
Slovenian: Po injiciranju zdravila se matične celice ne premaknejo ali porazdelijo iz zdravljenega sklepa in sinovije v tkiva, ki obdajajo sinovijski prostor.
English: Use a needle with a diameter greater than or equal to 22G in order to prevent cell damage.
Slovenian: Uporabite iglo s premerom vsaj 22 G, da ne poškodujete celic.
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Each 2 ml dose - contains:
Slovenian: KAKOVOSTNA IN KOLIČINSKA SESTAVA En 2-ml odmerek vsebuje:
English: According to the benefit-risk assessment of the responsible veterinarian of the individual case a single dose systemic NSAID may be administered on the day of intraarticular injection.
Slovenian: Glede na oceno razmerja korist-tveganje odgovornega veterinarja za vsak posamezni primer, se enkratni odmerek sistemskega nesteroidnega protivnetnega zdravila lahko da na isti dan kot intraartikularna injekcija.
English: Overdose: No data available
Slovenian: Preveliko odmerjanje: Ni podatkov.
English: If any cell clusters are visible in either of the vials after thawing, gently shake the vial concerned until the suspension is clear and colourless (stem cell suspension) or clear and yellow (equine allogeneic plasma suspension: the diluent).
Slovenian: Če v kateri koli viali po odtalitvi opazite skupke celic, vialo nežno stresajte, dokler suspenzija ne postane bistra in brezbarvna (suspenzija matičnih celic) oziroma bistra in rumena (suspenzija konjske alogenske plazme: redčilo).
English: The veterinary product must be administered intraarticularly by a veterinary surgeon taking special precautions to ensure sterility of the injection process.
Slovenian: Zdravilo mora veterinar dati intraartikularno in pri tem upoštevati previdnostne ukrepe za zagotavljanje sterilnosti postopka injiciranja.
English: Cyclo-olefin co-polymer (COC) vial with a thermoplastic elastomer (TPE) stopper and a high-density polyethylene (HDPE) cap.
Slovenian: Viala iz kopolimera cikloolefina (COC) z zamaškom iz termoplastičnega elastomera (TPE) in zaporko iz polietilena visoke gostote (HDPE).
English: The product needs to be administered immediately after thawing to prevent significant cell death.
Slovenian: Zdravilo je treba dati takoj, ko se odtali, da se prepreči večje odmiranje celic.
English: STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENT(S) Each dose (2 ml) contains:
Slovenian: NAVEDBA UČINKOVIN(E) IN DRUGE(IH) SESTAVIN En odmerek (2 ml) vsebuje:
English: Dosage: A single intraarticular injection of 1 dose (2 ml) per animal.
Slovenian: Odmerjanje: Ena intraartikularna injekcija 1 odmerka (2 ml) na žival.
English: In case of accidental self-injection this product can cause pain, local inflammatory reactions and swelling at the site of injection which may persist for several weeks and possibly cause fever, seek medical advice immediately and show the package leaflet or the label to the physician.
Slovenian: V primeru nenamernega samoinjiciranja to zdravilo lahko povzroči bolečino, lokalne vnetne reakcije in otekanje na mestu injiciranja, ki lahko traja več tednov in lahko povzroči povišano telesno temperaturo.
English: Shelf life after preparation of the suspension for injection according to directions: use immediately
Slovenian: Rok uporabnosti po pripravi suspenzije za injiciranje v skladu z navodili: uporabite takoj.
English: Shelf life after reconstitution according to directions: Use immediately.
Slovenian: Rok uporabnosti po rekonstituciji v skladu z navodili: uporabite takoj.
English: Remove the cap of the vial that thawed first and aspirate the suspension in a syringe, then remove the cap of the other (thawed) vial and aspirate the suspension in the same syringe.
Slovenian: Odstranite zaporko z viale, ki se je prva odtalila, in suspenzijo potegnite v injekcijsko brizgo, nato odstranite zaporko druge (odtaljene) viale in potegnite suspenzijo v isto injekcijsko brizgo.
English: The chondrogenic induction of the mesenchymal stem cells aims to activate chondroprotective mechanisms, such as the production of extracellular matrix.
Slovenian: S hondrogeno indukcijo mezenhimskih matičnih celic se aktivirajo hondroprotektivni mehanizmi, kot je tvorba zunajceličnega matriksa.
English: Active substance (1 ml):
Slovenian: Pomožne snovi (1 ml):
English: A. MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCE AND
Slovenian: A. PROIZVAJALEC BIOLOŠKE UČINKOVINE IN PROIZVAJALEC ZDRAVILA,
English: The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals treated displaying adverse reaction(s)) - common (more than 1 but less than 10 animals in 100 animals treated) - uncommon (more than 1 but less than 10 animals in 1,000 animals treated) - rare (more than 1 but less than 10 animals in 10,000 animals treated)
Slovenian: Pogostost neželenih učinkov je določena po naslednjem dogovoru: - zelo pogosti (neželeni učinki se pokažejo pri več kot 1 od 10 zdravljenih živali) - pogosti (pri več kot 1, toda manj kot 10 živalih od 100 zdravljenih živali) - občasni (pri več kot 1, toda manj kot 10 živalih od 1 000 zdravljenih živali) - redki (pri več kot 1, toda manj kot 10 živalih od 10 000 zdravljenih živali)